comparemela.com

Latest Breaking News On - Junshi bioscience - Page 1 : comparemela.com

Junshi Biosciences Announces 2023 Full Year Financial

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading.

Indonesia
Brunei
Panama
Beijing
China
Shanghai
New-zealand
India
Argentina
Guangzhou
Guangdong
Uruguay

Junshi Biosciences Announces 2023 Full Year Financial Results And Provides Corporate Updates

Junshi Biosciences Announces 2023 Full Year Financial Results And Provides Corporate Updates
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Argentina
New-zealand
Australia
Suzhou
Jiangsu
China
India
Beijing
Panama
San-francisco
California
United-states

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…

Ottawa
Ontario
Canada
Vietnam
Republic-of
Uruguay
Brunei
Laos
China
Shanghai
Brazil
Guangzhou

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region
quicknews-africa.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from quicknews-africa.net Daily Mail and Mail on Sunday newspapers.

China
United-states
London
City-of
United-kingdom
Chinese
Junshi-bioscience
Junshi-biosciences
Mazen-darwazeh
Hikma-pharmaceuticals
Middle-east
North-africa

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Beijing
China
United-states
Suzhou
Jiangsu
Maryland
Shanghai
Guangzhou
Guangdong
Massachusetts
California
Chinese

vimarsana © 2020. All Rights Reserved.